Augmedix Stock Current Valuation
AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Valuation analysis of Augmedix helps investors to measure Augmedix's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Augmedix's price fluctuation is somewhat reliable at this time. Calculation of the real value of Augmedix is based on 3 months time horizon. Increasing Augmedix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Augmedix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Augmedix Stock. However, Augmedix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 2.35 | Real 1.69 | Hype 2.35 | Naive 2.29 |
The intrinsic value of Augmedix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Augmedix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Augmedix helps investors to forecast how Augmedix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Augmedix more accurately as focusing exclusively on Augmedix's fundamentals will not take into account other important factors: Augmedix Company Current Valuation Analysis
Augmedix's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Augmedix Current Valuation | 113.21 M |
Most of Augmedix's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Augmedix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Augmedix has a Current Valuation of 113.21 M. This is 99.21% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.32% higher than that of the company.
Augmedix Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Augmedix's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Augmedix could also be used in its relative valuation, which is a method of valuing Augmedix by comparing valuation metrics of similar companies.Augmedix is currently under evaluation in current valuation category among its peers.
Augmedix Fundamentals
Return On Equity | -3.3 | |||
Return On Asset | -0.31 | |||
Profit Margin | (0.46) % | |||
Operating Margin | (0.64) % | |||
Current Valuation | 113.21 M | |||
Shares Outstanding | 49.43 M | |||
Shares Owned By Insiders | 1.50 % | |||
Shares Owned By Institutions | 84.78 % | |||
Number Of Shares Shorted | 1.07 M | |||
Price To Book | 11.09 X | |||
Price To Sales | 2.25 X | |||
Revenue | 44.85 M | |||
Gross Profit | 13.95 M | |||
EBITDA | (17.68 M) | |||
Net Income | (19.17 M) | |||
Cash And Equivalents | 29.99 M | |||
Cash Per Share | 0.80 X | |||
Total Debt | 25.85 M | |||
Debt To Equity | 1.54 % | |||
Current Ratio | 2.89 X | |||
Book Value Per Share | 0.21 X | |||
Cash Flow From Operations | (15.44 M) | |||
Short Ratio | 5.73 X | |||
Earnings Per Share | (0.47) X | |||
Target Price | 2.92 | |||
Number Of Employees | 1.43 K | |||
Beta | -0.19 | |||
Market Capitalization | 116.16 M | |||
Total Asset | 66.71 M | |||
Retained Earnings | (144.96 M) | |||
Working Capital | 33.2 M | |||
Net Asset | 66.71 M |
About Augmedix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Augmedix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Augmedix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Augmedix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |